226 related articles for article (PubMed ID: 26143113)
1. Clinically and Statistically Significant Changes Seen in Sham Surgery Arms of Randomized, Controlled Benign Prostatic Hyperplasia Surgery Trials.
Welliver C; Kottwitz M; Feustel P; McVary K
J Urol; 2015 Dec; 194(6):1682-7. PubMed ID: 26143113
[TBL] [Abstract][Full Text] [Related]
2. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
Elshal AM; Elmansy HM; Elhilali MM
BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
[TBL] [Abstract][Full Text] [Related]
4. A Relevant Midterm (12 Months) Placebo Effect on Lower Urinary Tract Symptoms and Maximum Flow Rate in Male Lower Urinary Tract Symptom and Benign Prostatic Hyperplasia-A Meta-analysis.
Eredics K; Madersbacher S; Schauer I
Urology; 2017 Aug; 106():160-166. PubMed ID: 28506862
[TBL] [Abstract][Full Text] [Related]
5. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
[TBL] [Abstract][Full Text] [Related]
6. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
McVary KT; Gange SN; Gittelman MC; Goldberg KA; Patel K; Shore ND; Levin RM; Rousseau M; Beahrs JR; Kaminetsky J; Cowan BE; Cantrill CH; Mynderse LA; Ulchaker JC; Larson TR; Dixon CM; Roehrborn CG
J Urol; 2016 May; 195(5):1529-1538. PubMed ID: 26614889
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo controlled study of onabotulinumtoxinA 200 U to treat lower urinary tract symptoms in men with benign prostatic hyperplasia.
McVary KT; Roehrborn CG; Chartier-Kastler E; Efros M; Bugarin D; Chen R; Patel A; Haag-Molkenteller C
J Urol; 2014 Jul; 192(1):150-6. PubMed ID: 24508634
[TBL] [Abstract][Full Text] [Related]
8. Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Roehrborn CG; Chapple C; Oelke M; Cox D; Esler A; Viktrup L
J Urol; 2014 Apr; 191(4):1045-50. PubMed ID: 24445278
[TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo controlled pilot study of intradetrusor injections of onabotulinumtoxinA for the treatment of refractory overactive bladder persisting following surgical management of benign prostatic hyperplasia.
Chughtai B; Dunphy C; Lee R; Lee D; Sheth S; Marks L; Kaplan SA; Te AE
Can J Urol; 2014 Apr; 21(2):7217-21. PubMed ID: 24775575
[TBL] [Abstract][Full Text] [Related]
10. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619
[TBL] [Abstract][Full Text] [Related]
11. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
[TBL] [Abstract][Full Text] [Related]
12. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
13. Urodynamic effects of transrectal intraprostatic Ona botulinum toxin A injections for symptomatic benign prostatic hyperplasia.
de Kort LM; Kok ET; Jonges TN; Rosier PF; Bosch JL
Urology; 2012 Oct; 80(4):889-93. PubMed ID: 22854138
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
[TBL] [Abstract][Full Text] [Related]
15. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.
Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
J Urol; 2015 Feb; 193(2):570-8. PubMed ID: 25219699
[TBL] [Abstract][Full Text] [Related]
16. Minimally invasive prostatic urethral lift: surgical technique and multinational experience.
McNicholas TA; Woo HH; Chin PT; Bolton D; Fernández Arjona M; Sievert KD; Schoenthaler M; Wetterauer U; Vrijhof EJ; Gange S; Montorsi F
Eur Urol; 2013 Aug; 64(2):292-9. PubMed ID: 23357348
[TBL] [Abstract][Full Text] [Related]
17. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
[TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia.
Boyle P; Robertson C; Vaughan ED; Fitzpatrick JM
BJU Int; 2004 Jul; 94(1):83-8. PubMed ID: 15217437
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
[TBL] [Abstract][Full Text] [Related]
20. A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
Novara G; Chapple CR; Montorsi F
BJU Int; 2014 Sep; 114(3):427-33. PubMed ID: 24571313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
